Logo image
Se connecter
Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
Article de revue   Avec comité de lecture

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

Gérard Helft, Claude Le Feuvre, Jean Louis Georges, Didier Carrie, Florence Leclercq, Hélène Eltchaninoff, Alain Furber, Fabrice Prunier, Laurent Sebagh, Simon Cattan, …
Trials, Vol.14(1), pp.56-56
21/02/2013
PMID: 23433461

Résumé

Study Protocol

Indicateurs

1 Consultations de la notice

Détails

Logo image